Angiosarcoma of the prostate gland following brachytherapy for prostatic adenocarcinoma

Arjun Gupta, Mrinal M. Patnaik, Harris V. Naina

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Prostatic adenocarcinoma is the most common cancer in men, but only a handful of cases of prostatic angiosarcoma have been reported in the literature. Prior radiation therapy for prostatic adenocarcinoma has been hypothesized to be a risk factor for angiosarcoma. The increasing practice of prostate cancer screening and the use of radiation therapy for management of prostatic adenocarcinoma will likely lead to more cases of prostatic angiosarcoma. Diagnosis is made by tissue sampling. Optimal management of these aggressive tumors remains to be defined and outcomes are poor with a high 1-year mortality. Primary care physicians and urologists should be aware of this rare entity and refer these patients to specialist centers where they can be managed by a multidisciplinary team. We report a case of angiosarcoma of the prostate gland diagnosed in a male presenting with lower urinary tract symptoms 5 years after brachytherapy for prostate adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)109-112
Number of pages4
JournalCurrent Urology
Volume8
Issue number2
DOIs
StatePublished - Aug 20 2014

Fingerprint

Hemangiosarcoma
Brachytherapy
Prostate
Adenocarcinoma
Radiotherapy
Lower Urinary Tract Symptoms
Primary Care Physicians
Early Detection of Cancer
Neoplasms
Prostatic Neoplasms
Mortality

Keywords

  • Prostate biopsy
  • Prostate cancer
  • Radiation-induced cancer
  • Sarcoma

ASJC Scopus subject areas

  • Oncology
  • Reproductive Medicine
  • Urology

Cite this

Angiosarcoma of the prostate gland following brachytherapy for prostatic adenocarcinoma. / Gupta, Arjun; Patnaik, Mrinal M.; Naina, Harris V.

In: Current Urology, Vol. 8, No. 2, 20.08.2014, p. 109-112.

Research output: Contribution to journalArticle

Gupta, Arjun ; Patnaik, Mrinal M. ; Naina, Harris V. / Angiosarcoma of the prostate gland following brachytherapy for prostatic adenocarcinoma. In: Current Urology. 2014 ; Vol. 8, No. 2. pp. 109-112.
@article{797c488535d74fca936e378b6ae9e360,
title = "Angiosarcoma of the prostate gland following brachytherapy for prostatic adenocarcinoma",
abstract = "Prostatic adenocarcinoma is the most common cancer in men, but only a handful of cases of prostatic angiosarcoma have been reported in the literature. Prior radiation therapy for prostatic adenocarcinoma has been hypothesized to be a risk factor for angiosarcoma. The increasing practice of prostate cancer screening and the use of radiation therapy for management of prostatic adenocarcinoma will likely lead to more cases of prostatic angiosarcoma. Diagnosis is made by tissue sampling. Optimal management of these aggressive tumors remains to be defined and outcomes are poor with a high 1-year mortality. Primary care physicians and urologists should be aware of this rare entity and refer these patients to specialist centers where they can be managed by a multidisciplinary team. We report a case of angiosarcoma of the prostate gland diagnosed in a male presenting with lower urinary tract symptoms 5 years after brachytherapy for prostate adenocarcinoma.",
keywords = "Prostate biopsy, Prostate cancer, Radiation-induced cancer, Sarcoma",
author = "Arjun Gupta and Patnaik, {Mrinal M.} and Naina, {Harris V.}",
year = "2014",
month = "8",
day = "20",
doi = "10.1159/000365700",
language = "English (US)",
volume = "8",
pages = "109--112",
journal = "Current Urology",
issn = "1661-7649",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Angiosarcoma of the prostate gland following brachytherapy for prostatic adenocarcinoma

AU - Gupta, Arjun

AU - Patnaik, Mrinal M.

AU - Naina, Harris V.

PY - 2014/8/20

Y1 - 2014/8/20

N2 - Prostatic adenocarcinoma is the most common cancer in men, but only a handful of cases of prostatic angiosarcoma have been reported in the literature. Prior radiation therapy for prostatic adenocarcinoma has been hypothesized to be a risk factor for angiosarcoma. The increasing practice of prostate cancer screening and the use of radiation therapy for management of prostatic adenocarcinoma will likely lead to more cases of prostatic angiosarcoma. Diagnosis is made by tissue sampling. Optimal management of these aggressive tumors remains to be defined and outcomes are poor with a high 1-year mortality. Primary care physicians and urologists should be aware of this rare entity and refer these patients to specialist centers where they can be managed by a multidisciplinary team. We report a case of angiosarcoma of the prostate gland diagnosed in a male presenting with lower urinary tract symptoms 5 years after brachytherapy for prostate adenocarcinoma.

AB - Prostatic adenocarcinoma is the most common cancer in men, but only a handful of cases of prostatic angiosarcoma have been reported in the literature. Prior radiation therapy for prostatic adenocarcinoma has been hypothesized to be a risk factor for angiosarcoma. The increasing practice of prostate cancer screening and the use of radiation therapy for management of prostatic adenocarcinoma will likely lead to more cases of prostatic angiosarcoma. Diagnosis is made by tissue sampling. Optimal management of these aggressive tumors remains to be defined and outcomes are poor with a high 1-year mortality. Primary care physicians and urologists should be aware of this rare entity and refer these patients to specialist centers where they can be managed by a multidisciplinary team. We report a case of angiosarcoma of the prostate gland diagnosed in a male presenting with lower urinary tract symptoms 5 years after brachytherapy for prostate adenocarcinoma.

KW - Prostate biopsy

KW - Prostate cancer

KW - Radiation-induced cancer

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84939546086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939546086&partnerID=8YFLogxK

U2 - 10.1159/000365700

DO - 10.1159/000365700

M3 - Article

C2 - 26889128

AN - SCOPUS:84939546086

VL - 8

SP - 109

EP - 112

JO - Current Urology

JF - Current Urology

SN - 1661-7649

IS - 2

ER -